Smartwatches and heart health in atrial fibrillation: how anxiety affects care use

Who could benefit from this research

What this research studies

If you have atrial fibrillation, this study looks at how using smartwatches with heart monitoring affects your feelings and health decisions. Participants will be randomly assigned to wear or not wear the device and will track anxiety levels and healthcare visits over time. The researchers will analyze whether anxious feelings link wearable alerts to more doctor visits or tests. The goal is to understand if these devices help or complicate care, so future recommendations can be tailored to patients. All activities are designed to clarify the patient experience and inform better wearable use in AF management.

Why it matters

Where this research is happening

• Univ of North Carolina Chapel Hill
  Chapel Hill, United States Active

Researchers

• Principal investigator: Rosman, Lindsey — Univ of North Carolina Chapel Hill
• Study coordinator: Rosman, Lindsey

Related research

Other NIH-funded projects on the same topics.

• Cardiomyocyte-fibroblast signaling in atrial fibrillation

  A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11617730

• Mobile app to help family caregivers in Thailand manage distress

  A mobile app called CAMMA would help family members caring for adults with chronic illnesses in Thailand feel less depressed and anxious through a culturally tailored mental health support program.

  NIH research Brigham and Women's Hospital · Boston, United States · NIH-11580924

• Anticoagulation in ICH Survivors with Atrial Fibrillation and Small Vessel Disease

  This project looks at how to safely use blood-thinning medicines in people who survived a brain bleed and also have atrial fibrillation and small vessel disease.

  NIH research Yale University · New Haven, United States · NIH-11533213

• Lowering heart inflammation to reduce atrial fibrillation risk in people with diabetes

  Seeing whether blocking a pro-inflammatory enzyme or boosting the heart's natural inflammation-resolving signals can lower atrial fibrillation risk in people with diabetes.

  NIH research University of Minnesota · Minneapolis, United States · NIH-11512008

• Atrial fibrillation, clots, and stroke: the heart’s JNK2 as a target

  This NIH grant explores how a heart protein called JNK2 may drive atrial fibrillation, blood clots, and stroke, and whether it could serve as a biomarker and new treatment approach.

  NIH research Ohio State University · Columbus, UNITED STATES · NIH-11465511

• A risk score to spot high-risk heart failure patients without atrial fibrillation who may need anticoagulation

  A new tool uses patient data and heart MRI markers to identify heart failure patients without atrial fibrillation who might benefit from anticoagulation while minimizing bleeding risk.

  NIH research University of Minnesota · Minneapolis, United States · NIH-11451573

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.